Johnson DL - Search Results

1

The TATA-binding protein as a regulator of cellular transformation.

Johnson SA, Dubeau L, White RJ, Johnson DL. Johnson SA, et al. Among authors: johnson dl. Cell Cycle. 2003 Sep-Oct;2(5):442-4. Cell Cycle. 2003. PMID: 12963838 Review.

2

Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis.

Johnson SA, Dubeau L, Kawalek M, Dervan A, Schönthal AH, Dang CV, Johnson DL. Johnson SA, et al. Among authors: johnson dl. Mol Cell Biol. 2003 May;23(9):3043-51. doi: 10.1128/MCB.23.9.3043-3051.2003. Mol Cell Biol. 2003. PMID: 12697807 Free PMC article.

3

Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation.

Johnson SA, Dubeau L, Johnson DL. Johnson SA, et al. Among authors: johnson dl. J Biol Chem. 2008 Jul 11;283(28):19184-91. doi: 10.1074/jbc.M802872200. Epub 2008 May 1. J Biol Chem. 2008. PMID: 18456653 Free PMC article.

4

Epidermal growth factor receptor 1 (EGFR1) and its variant EGFRvIII regulate TATA-binding protein expression through distinct pathways.

Fromm JA, Johnson SA, Johnson DL. Fromm JA, et al. Among authors: johnson dl, johnson sa. Mol Cell Biol. 2008 Oct;28(20):6483-95. doi: 10.1128/MCB.00288-08. Epub 2008 Aug 18. Mol Cell Biol. 2008. PMID: 18710943 Free PMC article.

5

Elevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer.

Johnson SAS, Lin JJ, Walkey CJ, Leathers MP, Coarfa C, Johnson DL. Johnson SAS, et al. Among authors: johnson dl. Oncotarget. 2017 Jul 25;8(30):48832-48845. doi: 10.18632/oncotarget.16384. Oncotarget. 2017. PMID: 28415573 Free PMC article.

6

Transcriptional regulation of the TATA-binding protein by Ras cellular signaling.

Johnson SA, Mandavia N, Wang HD, Johnson DL. Johnson SA, et al. Among authors: johnson dl. Mol Cell Biol. 2000 Jul;20(14):5000-9. doi: 10.1128/MCB.20.14.5000-5009.2000. Mol Cell Biol. 2000. PMID: 10866657 Free PMC article.

7

PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex.

Woiwode A, Johnson SA, Zhong S, Zhang C, Roeder RG, Teichmann M, Johnson DL. Woiwode A, et al. Among authors: johnson dl, johnson sa. Mol Cell Biol. 2008 Jun;28(12):4204-14. doi: 10.1128/MCB.01912-07. Epub 2008 Apr 7. Mol Cell Biol. 2008. PMID: 18391023 Free PMC article.

8

Cell biology. RNA metabolism and oncogenesis.

Johnson DL, Johnson SA. Johnson DL, et al. Among authors: johnson sa. Science. 2008 Apr 25;320(5875):461-2. doi: 10.1126/science.1158680. Science. 2008. PMID: 18436765 No abstract available.

9

Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism.

Palian BM, Rohira AD, Johnson SA, He L, Zheng N, Dubeau L, Stiles BL, Johnson DL. Palian BM, et al. Among authors: johnson dl, johnson sa. PLoS Genet. 2014 Dec 11;10(12):e1004789. doi: 10.1371/journal.pgen.1004789. eCollection 2014 Dec. PLoS Genet. 2014. PMID: 25502566 Free PMC article.

10

p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB.

Crighton D, Woiwode A, Zhang C, Mandavia N, Morton JP, Warnock LJ, Milner J, White RJ, Johnson DL. Crighton D, et al. Among authors: johnson dl. EMBO J. 2003 Jun 2;22(11):2810-20. doi: 10.1093/emboj/cdg265. EMBO J. 2003. PMID: 12773395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

848 results

Search Page

Filters